Evan Kurtz

Stock Analyst at BMO Capital

(0.49)
# 4,189
Out of 5,157 analysts
22
Total ratings
33.33%
Success rate
-18.36%
Average return

Stocks Rated by Evan Kurtz

Regeneron Pharmaceuticals
Mar 14, 2023
Maintains: Outperform
Price Target: $1,001$1,025
Current: $774.66
Upside: +32.32%
Warrior Met Coal
Oct 2, 2018
Maintains: Equal-Weight
Price Target: $27$29
Current: $84.69
Upside: -65.76%
Steel Dynamics
Aug 27, 2018
Upgrades: Overweight
Price Target: $50$52
Current: $184.26
Upside: -71.78%
Constellium SE
Aug 1, 2018
Maintains: Overweight
Price Target: $15$16
Current: $25.33
Upside: -36.83%
Nucor
Apr 17, 2018
Maintains: Equal-Weight
Price Target: $68$73
Current: $171.81
Upside: -57.51%